Bausch Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BAUSCH, and when can generic versions of BAUSCH drugs launch?
BAUSCH has one hundred and seventy-six approved drugs.
There are one hundred and twenty-one US patents protecting BAUSCH drugs.
There are seven hundred and seventy-one patent family members on BAUSCH drugs in fifty-two countries and two hundred and eight supplementary protection certificates in sixteen countries.
Summary for Bausch
International Patents: | 771 |
US Patents: | 121 |
Tradenames: | 155 |
Ingredients: | 122 |
NDAs: | 176 |
Patent Litigation for Bausch: | See patent lawsuits for Bausch |
Drugs and US Patents for Bausch
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch And Lomb | LATANOPROST | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 201006-001 | Mar 22, 2011 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bausch And Lomb Inc | XIIDRA | lifitegrast | SOLUTION/DROPS;OPHTHALMIC | 208073-001 | Jul 11, 2016 | AB | RX | Yes | Yes | 9,890,141 | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
Bausch | SOLODYN | minocycline hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 050808-007 | Aug 27, 2010 | AB | RX | Yes | No | 8,268,804 | ⤷ Try a Trial | ⤷ Try a Trial | |||
Bausch | VASERETIC | enalapril maleate; hydrochlorothiazide | TABLET;ORAL | 019221-003 | Jul 12, 1995 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Bausch
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch | RETIN-A MICRO | tretinoin | GEL;TOPICAL | 020475-002 | May 10, 2002 | 4,690,825 | ⤷ Try a Trial |
Bausch | VIRAZOLE | ribavirin | FOR SOLUTION;INHALATION | 018859-001 | Dec 31, 1985 | 4,211,771 | ⤷ Try a Trial |
Bausch | CESAMET | nabilone | CAPSULE;ORAL | 018677-001 | Dec 26, 1985 | 4,087,545 | ⤷ Try a Trial |
Bausch | SOLODYN | minocycline hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 050808-005 | Jul 23, 2009 | 5,908,838 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for BAUSCH drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | For Inhalation Solution | 6 gm/vial | ➤ Subscribe | 2014-05-22 |
➤ Subscribe | Extended-release Tablets | 420 mg | ➤ Subscribe | 2005-04-25 |
➤ Subscribe | Rectal Gel | 5 mg/mL, 4mL pre-filled syringe | ➤ Subscribe | 2008-12-08 |
➤ Subscribe | Extended-release Tablet | 55 mg and 80 mg | ➤ Subscribe | 2010-12-02 |
➤ Subscribe | Gel | 1.2%/2.5% | ➤ Subscribe | 2012-12-20 |
➤ Subscribe | Extended-release Tablets | 150 mg and 300 mg | ➤ Subscribe | 2004-09-21 |
➤ Subscribe | Gel | 0.1% | ➤ Subscribe | 2010-07-08 |
➤ Subscribe | Ophthalmic Solution | 0.07% | ➤ Subscribe | 2013-07-26 |
➤ Subscribe | Capsules | 75 mg | ➤ Subscribe | 2011-06-06 |
➤ Subscribe | Vaginal Gel | 0.75% | ➤ Subscribe | 2004-09-02 |
➤ Subscribe | Cream | 5% | ➤ Subscribe | 2006-10-17 |
➤ Subscribe | Topical Solution | 10% | ➤ Subscribe | 2018-06-06 |
➤ Subscribe | Cream | 0.10% | ➤ Subscribe | 2008-01-31 |
➤ Subscribe | Extended-release Tablets | 348 mg | ➤ Subscribe | 2009-09-24 |
➤ Subscribe | Cream | 2.5% | ➤ Subscribe | 2014-06-17 |
➤ Subscribe | Extended-release Tablets | 120 mg, 180 mg, 240 mg, 300 mg and 360 mg | ➤ Subscribe | 2005-08-30 |
➤ Subscribe | Rectal Gel | 2.5 mg/0.5 mL, 5 mg/mL, 10 mg/2 mL, 15 mg/3 mL and 20 mg/4 mL | ➤ Subscribe | 2004-03-23 |
➤ Subscribe | Extended-release Tablets | 65 mg and 115 mg | ➤ Subscribe | 2009-11-19 |
➤ Subscribe | Rectal Gel | 5 mg/mL, 2mL pre-filled syringe | ➤ Subscribe | 2008-12-23 |
➤ Subscribe | Extended-release Tablet | 105 rng | ➤ Subscribe | 2010-12-28 |
➤ Subscribe | Gel | 1.2%/3.75% | ➤ Subscribe | 2015-09-30 |
➤ Subscribe | Ophthalmic Solution | 0.5% | ➤ Subscribe | 2012-10-19 |
➤ Subscribe | Gel | 0.04% | ➤ Subscribe | 2010-12-20 |
➤ Subscribe | Ophthalmic Solution | 1.5% | ➤ Subscribe | 2013-09-09 |
➤ Subscribe | Gel | 1.2%/0.025% | ➤ Subscribe | 2010-12-17 |
➤ Subscribe | Gel | 0.77% | ➤ Subscribe | 2006-05-10 |
➤ Subscribe | Lotion | 0.1% | ➤ Subscribe | 2016-08-31 |
➤ Subscribe | Extended-release Tablets | 174 mg | ➤ Subscribe | 2009-09-28 |
➤ Subscribe | Cream | 3.75% | ➤ Subscribe | 2012-08-08 |
➤ Subscribe | Extended-release Tablets | 522 mg | ➤ Subscribe | 2009-12-24 |
International Patents for Bausch Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Ukraine | 84726 | ⤷ Try a Trial |
Japan | 5808037 | ⤷ Try a Trial |
African Intellectual Property Organization (OAPI) | 13356 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2010051291 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Bausch Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0145340 | SPC/GB99/003 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: IMIQUIMOD; REGISTERED: UK EU/1/98/080/001 19980918 |
1912999 | 1490062-5 | Sweden | ⤷ Try a Trial | PRODUCT NAME: SIMEPREVIR, OR A SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516 |
2444079 | C02444079/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: LIFITEGRAST; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66850 19.12.2018 |
3461484 | 122021000036 | Germany | ⤷ Try a Trial | PRODUCT NAME: LATANOPROST, ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, UND NETARSUDIL MESYLAT; REGISTRATION NO/DATE: EU/1/20/1502 20210107 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.